Showing 1 - 10 of 29
Persistent link: https://www.econbiz.de/10012116076
Persistent link: https://www.econbiz.de/10003872529
Persistent link: https://www.econbiz.de/10003834323
Persistent link: https://www.econbiz.de/10001686610
Persistent link: https://www.econbiz.de/10001686611
Persistent link: https://www.econbiz.de/10001686612
Persistent link: https://www.econbiz.de/10001550354
Persistent link: https://www.econbiz.de/10001553923
We study the relationship between regulatory regimes and pharmaceutical firms’ pricing strategies using a unique policy experiment from Norway, which in 2003 introduced a reference price (RP) system called “index pricing” for a sub-sample of off-patent pharmaceuticals, replacing the...
Persistent link: https://www.econbiz.de/10008918545
We study the relationship between regulatory regimes and pharmaceutical firms' pricing strategies using a unique policy experiment from Norway, which in 2003 introduced a reference price (RP) system called index pricing for a sub-sample of off-patent pharmaceuticals, replacing the existing price...
Persistent link: https://www.econbiz.de/10010264178